News

PATH/Matthew Dakin
GHTC sends FY21 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2021 (FY21) budget.

PDF

PATH/Matthew Dakin
GHTC op-ed featured in The Hill

A commentary piece authored by GHTC Director Jamie Bay Nishi on the steady and substantial funding necessary to drive breakthrough innovations for global health threats was featured in The Hill

View

PATH/Wendy Stone
GHTC Director quoted in The Hill on Ebola vaccine development

The Hill quoted GHTC Director Jamie Bay Nishi in an article on Ebola vaccine development. 

View

PATH/Wendy Stone
GHTC Director quoted in The Verge on product development for emerging and infectious diseases

The Verge quoted GHTC Director Jamie Bay Nishi in an article on developing drugs and products amidst an outbreak.

View

PATH/Katrina Peach
GHTC Director quoted in CIDRAP on FDA approval of a new drug for highly resistant tuberculosis

CIDRAP quoted GHTC Director Jamie Bay Nishi in an article on the FDA approval of a new drug to treat highly resistant tuberculosis.

View

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide